Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-07 Option Award | 2024-05-09 4:30 pm | N/A 2034-05-07 | Merus N.V. | MRUS | Pucci Paolo Director | 8,844 | $0 | 8,844 (Direct) | View |
| 2024-04-23 Option Award | 2024-04-25 4:55 pm | N/A N/A | WEST PHARMACEUTICAL SERVICES INC | WST | Pucci Paolo Director | 564 | $0 | 9,876 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:02 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Pucci Paolo Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:16 pm | N/A 2033-06-08 | Merus N.V. | MRUS | Pucci Paolo Director | 14,414 | $0 | 14,414 (Direct) | View |
| 2023-04-25 Option Award | 2023-04-27 5:17 pm | N/A N/A | WEST PHARMACEUTICAL SERVICES INC | WST | Pucci Paolo Director | 616 | $0 | 9,312 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-04 8:04 pm | N/A 2033-04-01 | Replimune Group Inc. | REPL | Pucci Paolo Director | 25,200 | $0 | 25,200 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 4:05 pm | N/A 2032-05-31 | Merus N.V. | MRUS | Pucci Paolo Director | 16,604 | $0 | 16,604 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 3:49 pm | N/A N/A | WEST PHARMACEUTICAL SERVICES INC | WST | Pucci Paolo Director | 632 | $0 | 8,696 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 4:09 pm | N/A 2032-04-01 | Replimune Group Inc. | REPL | Pucci Paolo Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2021-11-17 Disposition | 2021-11-19 1:33 pm | N/A 2030-11-15 | Trillium Therapeutics Inc. | TRIL | Pucci Paolo Director | 67,000 | $0 | 0 (Direct) | View |
| 2021-05-28 Option Award | 2021-06-02 4:10 pm | N/A 2031-05-28 | Merus N.V. | MRUS | Pucci Paolo Director | 6,120 | $0 | 6,120 (Direct) | View |
| 2021-05-04 Option Award | 2021-05-06 7:29 pm | N/A N/A | WEST PHARMACEUTICAL SERVICES INC | WST | Pucci Paolo Director | 577 | $0 | 8,064 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-05 8:14 pm | N/A 2031-04-01 | Replimune Group Inc. | REPL | Pucci Paolo Director | 16,500 | $0 | 16,500 (Direct) | View |
Ownership | 2021-01-04 8:22 pm | N/A 2030-11-15 | Trillium Therapeutics Inc. | TRIL | Pucci Paolo Director | 0 | $0 | 67,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:00 pm | N/A 2030-06-30 | Merus N.V. | MRUS | Pucci Paolo Director | 17,262 | $0 | 17,262 (Direct) | View |
| 2020-05-05 Option Award | 2020-05-07 6:06 pm | N/A N/A | WEST PHARMACEUTICAL SERVICES INC | WST | Pucci Paolo Director | 975 | $0 | 7,470 (Direct) | View |
| 2020-04-01 Option Award | 2020-04-02 4:32 pm | N/A 2030-04-01 | Replimune Group Inc. | REPL | Pucci Paolo Director | 33,000 | $0 | 33,000 (Direct) | View |
| 2020-01-16 Equity Swap | 2020-01-16 3:56 pm | N/A N/A | ARQULE INC | ARQL | Pucci Paolo Chief Executive Officer | 1,235,782 | $20 | 0 (Direct) | View |
| 2020-01-16 Disposition | 2020-01-16 3:56 pm | N/A 2025-01-20 | ARQULE INC | ARQL | Pucci Paolo Chief Executive Officer | 3,104,855 | $0 | 0 (Direct) | View |